OCUMENSION-B: 2023 Environmental, Social and Governance Report
Apr 25 17:14
OCUMENSION-B: 2023 Annual Report
Apr 25 17:05
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA
Apr 15 12:07
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA
Apr 8 12:00
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024
Apr 3 19:37
OCUMENSION-B: (I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
Mar 22 06:07
OCUMENSION-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Mar 21 22:32
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE II CLINICAL TRIAL OF OT-202
Mar 14 12:00
OCUMENSION-B: DATE OF BOARD MEETING
Mar 7 18:53
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024
Mar 1 16:16
OCUMENSION-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Feb 9 16:07
OCUMENSION-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Feb 9 16:03
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024
Feb 1 20:22
OCUMENSION-B: Next Day Disclosure Return
Jan 19 19:34
OCUMENSION-B: Next Day Disclosure Return
Jan 18 22:04
OCUMENSION-B: Next Day Disclosure Return
Jan 17 18:34
OCUMENSION-B: DISCLOSEABLE TRANSACTION DISPOSAL OF SHARES IN EYEPOINT PHARMACEUTICALS, INC.
Jan 17 07:58
OCUMENSION-B: Next Day Disclosure Return
Jan 16 20:51
OCUMENSION-B: Next Day Disclosure Return
Jan 15 19:30
OCUMENSION-B: Next Day Disclosure Return
Jan 12 18:15
No Data
No Data